News
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
California pension fund CalPERS, the second-largest public purchaser of health benefits in the U.S., announced on Tuesday ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results